Jump to content
Menu
Search
Search
To the medication query
DE
EN
Home
NADA
Overview
Organisation
Overview
Supervisory Board
Executive Board
Staff
Commissions
National and International Involvement
Sponsoring and Partner
Annual Reports
SPEAK UP
Internal Whistleblower Tool
Legal matters
Overview
WADC
Overview
Standards
NADC
Anti-Doping Law
Sanctions
Overview
Results management
Disciplinary proceeding
Sport jurisdiction
Intelligence and Investigations
Data Protection
Anti-Doping Law
Medicine
Overview
Current Medical Advice
Overview
Asthma medication in sport
Cortisone in sport
Prohibited List
Overview
Important changes to the 2024 Prohibited List
In case of disease: Therapeutic Use Exemption (TUE)
Overview
Regulation for non-testing pool athletes
Regulation for testing pool athletes
Digital list of permitted pharmaceuticals
NADAmed
Doping traps
Testing
Overview
Testing Programme
Overview
Research
Testing Process
Overview
Doping analytics
Participants in the control process
Out-of-competition Testing
Overview
Testpools
Risk groups
Whereabouts information
In-competition Testing
ADAMS
Medication controls for horses
Education
Overview
TOGETHER AGAINST DOPING
Training courses
UEFA EURO 2024
e-Learning
Service
Overview
News
Media
Blog
Calender
Downloads
Scientific Publications
Knowledge Centre
FAQ
Videos
Newsletter
Jobs
Digital Resources
HINWEIS: Diese Website ist für Internet Explorer nicht optimiert. Bitte verwenden Sie einen anderen Browser.
You are here:
nada.de
Contact
Back
Share page
Subscribe to the newsletter
Thank you for your enquiry
We will answer your enquiry as soon as possible.
Modal Title
schliessen
Vorheriges
Nächstes
Modal Title
schliessen